PRESCRIBING PATTERNS OF ANTIDEPRESSANTS IN WAD MEDANI AREA, SUDAN
Abstract
Background: The important considerations in prescribing antidepressants are their safety and tolerability. Selective serotonin re-uptake inhibitors (SSRIs) are known to be as equally effective as tricyclic antidepressants (TCAs) with fewer side effects profile and better tolerance.
Objective: The primary aim of this study was to determine the prescribing patterns of antidepressants in Wed Medani area.
Methodology: This cross-sectional, prospective hospital based study assesses the prescription pattern of antidepressant. It was conducted at Wed Medani Psychiatric Teaching Hospital and Hantoub Psychiatric Asylum and Clinic. 500 psychiatric prescriptions were selected at random using a data collection form and analyzed by SPSS.
Result: The most commonly prescribed CNS affecting drugs were antipsychotic agents, antidepressants, and antiepileptics. One hundred and fifty (30%) of the 500 prescriptions contained antidepressants. Selective serotonin reuptake inhibitors were prescribed in 25 (16.7%) prescriptions while TCAs were included in 125 (83.3%). It was observed that only 33 (22%) of antidepressants prescriptions followed standard treatment guidelines.
Conclusion: To improve the quality of care and to achieve benefits, treatment should be based on current best research evidence treatment guidelines for therapy of depression.
References
2. Barber, N (1995). What constitutes good prescribing? British Medical Journal, 310:923-925.
3. Anderson, I., M. and Tomenson, B., M. (1995). Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. British Medical Journal, 310:1433-1438.
4. Bradley, CP (1991).Decision making and prescribing patterns — a literature review. Family Practice, 8:276-287.
5. Dipiro, JT; Talbert, R L; Yee, GC; Matzke, GR; Wells and Posey, LM, Ed (2005) . Pharmacotherapy. 6th edition. 67, 1235-1255. New York: McGraw-Hill.
6. Gillman, Goodman, Alfred; Hardman, Joel, G. and Lee, E, Limbird (2008). Goodman & Gilman’s Manual of Pharmacology and Therapeutics. New York: McGraw-Hill. 1131-1133.
7. Khandelwal, S.; Chowdhury, A.; Regmi, S.K.; Mendisn N. And Kittirattanapaiboon P. (2001). Conquering Depression. New Delhi: World Health Organization Regional Office for South-East Asia.
8. Kumari, R.; Idris, MZ. ; Bhushan, V.; Khanna, A.; Agrawal, A. And Kumar, A. (2008). Assessment of prescription pattern at the public health facilities of Lucknow district, Indian Journal of pharmacology, 40: 243-247.
9. Mann, J., J. (2005).The Medical Management of Depression .The New England Journal of Medicine, 353:1819-1834.
10. Neal, M., J. (2002). Medical Pharmacology at a Glance. 4th edition. London: Blackwell.42-43
11. Paykel, E. S. and Priest, R. G., (1992). Recognition and management of depression in general practice: consensus statement. British Medical Journal, 305(6863): 1198–1202.
12. Peretti, S.; Judge, R. And Hindmarch, I., (2000). Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors. Acta Psychiatrica Scandinavica .101: 17–25.
13. Rang, H.P.; Dale, M.M.; Ritter J.M. and Flower, R.J., (2007) .RANG and DALE`S Pharmacology. 6th edition. Churchill: livingstone Elsevier.534-548
14. Sharif, SI. ; Al-Shaqra, M.; Hajjar, H.; Shamout, A. and Wess, L ., (2007) . Patterns of drug prescribing in a hospital in Dubai, United Arab Emirates. Libyan J Med, AOP: 070928.
15. Shargel, L; Mutnik, AH; Souney, PF and Swanson, LN. Ed. (2010). Comprehensive Pharmacy Review.7th edition.1,558.Phlidelphia:wolters kluwer/lippinott.
16. WHO (1993) : How to investigate drug use in health facilities: selected drug use indicator.DAP/93.1, 12-43.
